Everest Medicines has announced that with the official implementation of the latest update of the National Reimbursement Drug List on 1st January 2025, NEFECON(R) will apply the NRDL pricing, which will benefit more IgA nephropathy (IgAN) patients.
Piezoelectric and triboelectric tactile sensors, crucial for applications in robotics and wearable devices, face challenges in flexibility and environmental resilience.
Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has announced capacity expansions at its sites in Rewari (IN) and Suzhou (CN).
Gaelic Laboratories, a European CMO based in Ireland, has established a subsidiary in the UAE, enabling access to the Middle East market – both for Gaelic Laboratories and its marketing partners looking to access this rapidly-growing region.
Since 2007, the contract laboratory Alphalyse A/S has developed and refined a new method of impurity analysis in biological pharmaceuticals based on mass spectrometry (MS).
ACG, a supplier of integrated manufacturing solutions for the pharmaceutical and nutraceutical industries, has announced the commencement of operations at its capsule manufacturing facility in Rayong, Thailand.
Merck has launched a beta version of M-Trust, a secure cyber-physical trust platform, created to help solve the growing issues of product safety, traceability and counterfeiting.
Sequana Medical NV, has announced that it has received Premarket Approval (PMA) from the US Food and Drug Administration (FDA) to market alfapump for the treatment of recurrent or refractory ascites due to liver cirrhosis in the United States.
Evaluate, a provider of market insights for the pharmaceutical industry, has released its 2025 Preview report featuring updated forecasts for the biopharma market for 2025.
Owen Mumford has announced that its exclusive agreement with Osaka-based NIPRO CORPORATION (NIPRO) to distribute drug delivery device UniSafe has achieved rapid early growth in combination product sales in Japan.
